Cisplatin and Etoposide in Chemotherapy-Refractory Advanced Breast Cancer (Q68356182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Cisplatin and etoposide in chemotherapy-refractory advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Cisplatin and Etoposide in Chemotherapy-Refractory Advanced Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

author name string

G. Giaccone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368973

2 January 2023

M. Donadio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368973

2 January 2023

P. Ferrati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368973

2 January 2023

A. Calciati

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368973

2 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3368973

2 January 2023

publication date

1 April 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

30 April 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3368973

full work available at URL

2 January 2023

http://journals.sagepub.com/doi/pdf/10.1177/030089168807400212

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

191-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

Podophyllotoxin derivative VP 16-213

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

2

2

125

Athanassiades P.

1986

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

2 January 2023

5

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

Cisplatin in the treatment of metastatic breast carcinoma: A prospective randomized trial of two dosage schedules

2 January 2023

7

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

Nonparametric Estimation from Incomplete Observations

2 January 2023

8

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

2 January 2023

9

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer

2 January 2023

12

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

Cancer Treatment Reports

13

63

1459

Schabel F.

1979

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

2 January 2023

14

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

Cancer Treatment Reports

15

63

1593

Sierocki J.S.

1979

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

Cancer Treatment Reports

17

65

443

Vaughn C.B.

1981

1 reference

https://api.crossref.org/works/10.1177/030089168807400212

2 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3368973%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference